0

Close
 
Upcoming Allied Market Research
2023
Orthopedic Joint Reconstruction Market

Orthopedic Joint Reconstruction Market

by Product Type (Demineralized Bone Matrix, Allograft, Bone Morphogenetic Protein, Viscosupplementation Products, Synthetic Bone Substitutes, Others), by Joint Type (Knee, Hip, Shoulder, Ankle, Others), by Technique (Joint Replacement, Implants, Bone Graft, Osteotomy, Arthroscopy, Resurfacing, Arthrodesis), by Biomaterial (Metallic, Polymeric, Ceramic, Natural) and by End User (Hospitals, Ambulatory Centers, Research Academic Institute): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare
Report Code: A11559
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Orthopedic Joint Reconstruction Market

Request Now !

Orthopedic Joint Reconstruction Market Statistics 2030:

Orthopedic joint reconstruction is a surgery performed for the re-establishment of the architecture of a joint; this helps in re-instating the function of the joint. Orthopedic joint reconstruction ranges from minor repairs of joints to total joint replacement. The treatment options under orthopedic joint reconstruction can offer temporary & mild pain relief or permanent solutions to joint disorders such as osteoarthritis. Some of the most common orthopedic joint reconstruction surgeries include joint replacement surgery, osteotomy, arthroscopy, resurfacing surgery, arthrodesis, and small joint surgery.

Impact of COVID-19 on the Market

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Coronavirus disease 2019 (COVID-19) has created an economic crisis in addition to the healthcare crisis. COVID-19 pandemic has stretched the healthcare system worldwide; developed countries are expected to cause an economic recession. The pandemic has an adverse impact on the healthcare system, resulting in a 50–70% drop in revenue from March. Many small hospitals, clinics, and nursing homes have been forced to shut their operations. In addition, social distancing and localized curfews have resulted in delayed elective surgical procedures. Furthermore, visa cancellations have led to an interruption in medical tourism and can negatively impact the orthopedic joint reconstruction market growth.

Top Impacting Factors

Rise has been witnessed in the prevalence of symptomatic post-inflammatory arthritis and osteoarthritis. As these patients might need treatments such as orthopedic joint reconstruction, they are influencing the market positively.

Over time, the design and features of orthopedic joint reconstruction devices have been improved. The procedures are now minimally invasive and have a shorter recovery time, which escalate the market growth.

Increase in public health insurance establishments and rise in healthcare expenditure by the government further influence the orthopedic joint reconstruction market positively.

However, high cost of implants used in orthopedic joint reconstruction therapies along with a rise in alternative treatment options such as physiotherapy, acupuncture, medications, and prolotherapy are some of the key factors declining the growth of the orthopedic joint reconstruction market.

Top Market Trends

With rapid proliferation of internet, patients have started referring to online resources and web-based tools to avail information about orthopedic disorders—the most common being osteoarthritis and rheumatoid arthritis.

Joint reconstruction has witnessed the introduction of several online tools that help guide patients through their surgeries. These tools further helps patients connect with orthopedic surgeons and provide post-surgery rehabilitation information.

For instance, in 2018, Zimmer Biomet collaborated with Apple, Inc., for the development of an application called “Zimmer Biomet mymobility.” This application is used to connect care providers and patients undergoing knee hip replacement surgeries.

The orthopedic joint reconstruction market is dominated by North America, as leading manufacturing companies that manufacture orthopedic implants operate in this region. However, Asia-Pacific is expected to grow significantly during the forecast period, due to rise in demand for progressive healing treatments. 

Key Benefits of the Report

  • This study presents the analytical depiction of the orthopedic joint reconstruction industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the orthopedic joint reconstruction market share.
  • The current market is quantitatively analyzed to highlight the orthopedic joint reconstruction market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed orthopedic joint reconstruction market analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Global Orthopedic Joint Reconstruction Market Report

  • Which are the leading players active in the orthopedic joint reconstruction market?
  • How is each segment of the market expected to grow during ?
  • What are the adoption trends for orthopedic joint reconstruction in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is orthopedic joint reconstruction?
  • What is the orthopedic joint reconstruction market prediction in the future?
  • What are the current trends and predicted trends?

 Orthopedic Joint Reconstruction Market Report Highlights

Aspects Details
By Product Type
  • Demineralized Bone Matrix
  • Allograft
  • Bone Morphogenetic Protein
  • Viscosupplementation Products
  • Synthetic Bone Substitutes
  • Others
By Joint Type
  • Knee
  • Hip
  • Shoulder
  • Ankle
  • Others
By Technique
  • Joint Replacement
  • Implants
  • Bone Graft
  • Osteotomy
  • Arthroscopy
  • Resurfacing
  • Arthrodesis
By Biomaterial
  • Metallic
  • Polymeric
  • Ceramic
  • Natural
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Rest of LAMEA)
By End User
  • Hospitals
  • Ambulatory Centers
  • Research & Academic Institute
Key Market Players Biotech GmbH, Evolutis India Pvt. Ltd., Ltd., Mathys Ltd, Elite Surgical, BioMedtrix, Johnson & Johnson Services Inc., B. Braun Melsungen AG, CeramTec Group, Limacorporate S.p.a., Corin, Bettlach, Beijing Chunlizhengda Medical Instruments Co.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Demineralized Bone Matrix

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Allograft

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Bone Morphogenetic Protein

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Viscosupplementation Products

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Synthetic Bone Substitutes

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Others

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

  • CHAPTER 5: ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY JOINT TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Joint Type

    • 5.2. Knee

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Hip

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Shoulder

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Ankle

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Others

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY TECHNIQUE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Technique

    • 6.2. Joint Replacement

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Implants

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Bone Graft

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Osteotomy

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Arthroscopy

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Resurfacing

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

    • 6.8. Arthrodesis

      • 6.8.1. Key Market Trends, Growth Factors and Opportunities

      • 6.8.2. Market Size and Forecast, By Region

      • 6.8.3. Market Share Analysis, By Country

  • CHAPTER 7: ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY BIOMATERIAL

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Biomaterial

    • 7.2. Metallic

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Polymeric

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Ceramic

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Natural

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY END USER

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By End User

    • 8.2. Hospitals

      • 8.2.1. Key Market Trends, Growth Factors and Opportunities

      • 8.2.2. Market Size and Forecast, By Region

      • 8.2.3. Market Share Analysis, By Country

    • 8.3. Ambulatory Centers

      • 8.3.1. Key Market Trends, Growth Factors and Opportunities

      • 8.3.2. Market Size and Forecast, By Region

      • 8.3.3. Market Share Analysis, By Country

    • 8.4. Research Academic Institute

      • 8.4.1. Key Market Trends, Growth Factors and Opportunities

      • 8.4.2. Market Size and Forecast, By Region

      • 8.4.3. Market Share Analysis, By Country

  • CHAPTER 9: ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY REGION

    • 9.1. Market Overview

      • 9.1.1 Market Size and Forecast, By Region

    • 9.2. North America

      • 9.2.1. Key Market Trends and Opportunities

      • 9.2.2. Market Size and Forecast, By Product Type

      • 9.2.3. Market Size and Forecast, By Joint Type

      • 9.2.4. Market Size and Forecast, By Technique

      • 9.2.5. Market Size and Forecast, By Biomaterial

      • 9.2.6. Market Size and Forecast, By End User

      • 9.2.7. Market Size and Forecast, By Country

      • 9.2.8. U.S. Orthopedic Joint Reconstruction Market

        • 9.2.8.1. Market Size and Forecast, By Product Type
        • 9.2.8.2. Market Size and Forecast, By Joint Type
        • 9.2.8.3. Market Size and Forecast, By Technique
        • 9.2.8.4. Market Size and Forecast, By Biomaterial
        • 9.2.8.5. Market Size and Forecast, By End User

      • 9.2.9. Canada Orthopedic Joint Reconstruction Market

        • 9.2.9.1. Market Size and Forecast, By Product Type
        • 9.2.9.2. Market Size and Forecast, By Joint Type
        • 9.2.9.3. Market Size and Forecast, By Technique
        • 9.2.9.4. Market Size and Forecast, By Biomaterial
        • 9.2.9.5. Market Size and Forecast, By End User

      • 9.2.10. Mexico Orthopedic Joint Reconstruction Market

        • 9.2.10.1. Market Size and Forecast, By Product Type
        • 9.2.10.2. Market Size and Forecast, By Joint Type
        • 9.2.10.3. Market Size and Forecast, By Technique
        • 9.2.10.4. Market Size and Forecast, By Biomaterial
        • 9.2.10.5. Market Size and Forecast, By End User

    • 9.3. Europe

      • 9.3.1. Key Market Trends and Opportunities

      • 9.3.2. Market Size and Forecast, By Product Type

      • 9.3.3. Market Size and Forecast, By Joint Type

      • 9.3.4. Market Size and Forecast, By Technique

      • 9.3.5. Market Size and Forecast, By Biomaterial

      • 9.3.6. Market Size and Forecast, By End User

      • 9.3.7. Market Size and Forecast, By Country

      • 9.3.8. France Orthopedic Joint Reconstruction Market

        • 9.3.8.1. Market Size and Forecast, By Product Type
        • 9.3.8.2. Market Size and Forecast, By Joint Type
        • 9.3.8.3. Market Size and Forecast, By Technique
        • 9.3.8.4. Market Size and Forecast, By Biomaterial
        • 9.3.8.5. Market Size and Forecast, By End User

      • 9.3.9. Germany Orthopedic Joint Reconstruction Market

        • 9.3.9.1. Market Size and Forecast, By Product Type
        • 9.3.9.2. Market Size and Forecast, By Joint Type
        • 9.3.9.3. Market Size and Forecast, By Technique
        • 9.3.9.4. Market Size and Forecast, By Biomaterial
        • 9.3.9.5. Market Size and Forecast, By End User

      • 9.3.10. Italy Orthopedic Joint Reconstruction Market

        • 9.3.10.1. Market Size and Forecast, By Product Type
        • 9.3.10.2. Market Size and Forecast, By Joint Type
        • 9.3.10.3. Market Size and Forecast, By Technique
        • 9.3.10.4. Market Size and Forecast, By Biomaterial
        • 9.3.10.5. Market Size and Forecast, By End User

      • 9.3.11. Spain Orthopedic Joint Reconstruction Market

        • 9.3.11.1. Market Size and Forecast, By Product Type
        • 9.3.11.2. Market Size and Forecast, By Joint Type
        • 9.3.11.3. Market Size and Forecast, By Technique
        • 9.3.11.4. Market Size and Forecast, By Biomaterial
        • 9.3.11.5. Market Size and Forecast, By End User

      • 9.3.12. UK Orthopedic Joint Reconstruction Market

        • 9.3.12.1. Market Size and Forecast, By Product Type
        • 9.3.12.2. Market Size and Forecast, By Joint Type
        • 9.3.12.3. Market Size and Forecast, By Technique
        • 9.3.12.4. Market Size and Forecast, By Biomaterial
        • 9.3.12.5. Market Size and Forecast, By End User

      • 9.3.13. Russia Orthopedic Joint Reconstruction Market

        • 9.3.13.1. Market Size and Forecast, By Product Type
        • 9.3.13.2. Market Size and Forecast, By Joint Type
        • 9.3.13.3. Market Size and Forecast, By Technique
        • 9.3.13.4. Market Size and Forecast, By Biomaterial
        • 9.3.13.5. Market Size and Forecast, By End User

      • 9.3.14. Rest Of Europe Orthopedic Joint Reconstruction Market

        • 9.3.14.1. Market Size and Forecast, By Product Type
        • 9.3.14.2. Market Size and Forecast, By Joint Type
        • 9.3.14.3. Market Size and Forecast, By Technique
        • 9.3.14.4. Market Size and Forecast, By Biomaterial
        • 9.3.14.5. Market Size and Forecast, By End User

    • 9.4. Asia-Pacific

      • 9.4.1. Key Market Trends and Opportunities

      • 9.4.2. Market Size and Forecast, By Product Type

      • 9.4.3. Market Size and Forecast, By Joint Type

      • 9.4.4. Market Size and Forecast, By Technique

      • 9.4.5. Market Size and Forecast, By Biomaterial

      • 9.4.6. Market Size and Forecast, By End User

      • 9.4.7. Market Size and Forecast, By Country

      • 9.4.8. China Orthopedic Joint Reconstruction Market

        • 9.4.8.1. Market Size and Forecast, By Product Type
        • 9.4.8.2. Market Size and Forecast, By Joint Type
        • 9.4.8.3. Market Size and Forecast, By Technique
        • 9.4.8.4. Market Size and Forecast, By Biomaterial
        • 9.4.8.5. Market Size and Forecast, By End User

      • 9.4.9. Japan Orthopedic Joint Reconstruction Market

        • 9.4.9.1. Market Size and Forecast, By Product Type
        • 9.4.9.2. Market Size and Forecast, By Joint Type
        • 9.4.9.3. Market Size and Forecast, By Technique
        • 9.4.9.4. Market Size and Forecast, By Biomaterial
        • 9.4.9.5. Market Size and Forecast, By End User

      • 9.4.10. India Orthopedic Joint Reconstruction Market

        • 9.4.10.1. Market Size and Forecast, By Product Type
        • 9.4.10.2. Market Size and Forecast, By Joint Type
        • 9.4.10.3. Market Size and Forecast, By Technique
        • 9.4.10.4. Market Size and Forecast, By Biomaterial
        • 9.4.10.5. Market Size and Forecast, By End User

      • 9.4.11. South Korea Orthopedic Joint Reconstruction Market

        • 9.4.11.1. Market Size and Forecast, By Product Type
        • 9.4.11.2. Market Size and Forecast, By Joint Type
        • 9.4.11.3. Market Size and Forecast, By Technique
        • 9.4.11.4. Market Size and Forecast, By Biomaterial
        • 9.4.11.5. Market Size and Forecast, By End User

      • 9.4.12. Australia Orthopedic Joint Reconstruction Market

        • 9.4.12.1. Market Size and Forecast, By Product Type
        • 9.4.12.2. Market Size and Forecast, By Joint Type
        • 9.4.12.3. Market Size and Forecast, By Technique
        • 9.4.12.4. Market Size and Forecast, By Biomaterial
        • 9.4.12.5. Market Size and Forecast, By End User

      • 9.4.13. Thailand Orthopedic Joint Reconstruction Market

        • 9.4.13.1. Market Size and Forecast, By Product Type
        • 9.4.13.2. Market Size and Forecast, By Joint Type
        • 9.4.13.3. Market Size and Forecast, By Technique
        • 9.4.13.4. Market Size and Forecast, By Biomaterial
        • 9.4.13.5. Market Size and Forecast, By End User

      • 9.4.14. Malaysia Orthopedic Joint Reconstruction Market

        • 9.4.14.1. Market Size and Forecast, By Product Type
        • 9.4.14.2. Market Size and Forecast, By Joint Type
        • 9.4.14.3. Market Size and Forecast, By Technique
        • 9.4.14.4. Market Size and Forecast, By Biomaterial
        • 9.4.14.5. Market Size and Forecast, By End User

      • 9.4.15. Indonesia Orthopedic Joint Reconstruction Market

        • 9.4.15.1. Market Size and Forecast, By Product Type
        • 9.4.15.2. Market Size and Forecast, By Joint Type
        • 9.4.15.3. Market Size and Forecast, By Technique
        • 9.4.15.4. Market Size and Forecast, By Biomaterial
        • 9.4.15.5. Market Size and Forecast, By End User

      • 9.4.16. Rest of Asia Pacific Orthopedic Joint Reconstruction Market

        • 9.4.16.1. Market Size and Forecast, By Product Type
        • 9.4.16.2. Market Size and Forecast, By Joint Type
        • 9.4.16.3. Market Size and Forecast, By Technique
        • 9.4.16.4. Market Size and Forecast, By Biomaterial
        • 9.4.16.5. Market Size and Forecast, By End User

    • 9.5. LAMEA

      • 9.5.1. Key Market Trends and Opportunities

      • 9.5.2. Market Size and Forecast, By Product Type

      • 9.5.3. Market Size and Forecast, By Joint Type

      • 9.5.4. Market Size and Forecast, By Technique

      • 9.5.5. Market Size and Forecast, By Biomaterial

      • 9.5.6. Market Size and Forecast, By End User

      • 9.5.7. Market Size and Forecast, By Country

      • 9.5.8. Brazil Orthopedic Joint Reconstruction Market

        • 9.5.8.1. Market Size and Forecast, By Product Type
        • 9.5.8.2. Market Size and Forecast, By Joint Type
        • 9.5.8.3. Market Size and Forecast, By Technique
        • 9.5.8.4. Market Size and Forecast, By Biomaterial
        • 9.5.8.5. Market Size and Forecast, By End User

      • 9.5.9. South Africa Orthopedic Joint Reconstruction Market

        • 9.5.9.1. Market Size and Forecast, By Product Type
        • 9.5.9.2. Market Size and Forecast, By Joint Type
        • 9.5.9.3. Market Size and Forecast, By Technique
        • 9.5.9.4. Market Size and Forecast, By Biomaterial
        • 9.5.9.5. Market Size and Forecast, By End User

      • 9.5.10. Saudi Arabia Orthopedic Joint Reconstruction Market

        • 9.5.10.1. Market Size and Forecast, By Product Type
        • 9.5.10.2. Market Size and Forecast, By Joint Type
        • 9.5.10.3. Market Size and Forecast, By Technique
        • 9.5.10.4. Market Size and Forecast, By Biomaterial
        • 9.5.10.5. Market Size and Forecast, By End User

      • 9.5.11. UAE Orthopedic Joint Reconstruction Market

        • 9.5.11.1. Market Size and Forecast, By Product Type
        • 9.5.11.2. Market Size and Forecast, By Joint Type
        • 9.5.11.3. Market Size and Forecast, By Technique
        • 9.5.11.4. Market Size and Forecast, By Biomaterial
        • 9.5.11.5. Market Size and Forecast, By End User

      • 9.5.12. Argentina Orthopedic Joint Reconstruction Market

        • 9.5.12.1. Market Size and Forecast, By Product Type
        • 9.5.12.2. Market Size and Forecast, By Joint Type
        • 9.5.12.3. Market Size and Forecast, By Technique
        • 9.5.12.4. Market Size and Forecast, By Biomaterial
        • 9.5.12.5. Market Size and Forecast, By End User

      • 9.5.13. Rest of LAMEA Orthopedic Joint Reconstruction Market

        • 9.5.13.1. Market Size and Forecast, By Product Type
        • 9.5.13.2. Market Size and Forecast, By Joint Type
        • 9.5.13.3. Market Size and Forecast, By Technique
        • 9.5.13.4. Market Size and Forecast, By Biomaterial
        • 9.5.13.5. Market Size and Forecast, By End User

  • CHAPTER 10: COMPETITIVE LANDSCAPE

    • 10.1. Introduction

    • 10.2. Top Winning Strategies

    • 10.3. Product Mapping Of Top 10 Player

    • 10.4. Competitive Dashboard

    • 10.5. Competitive Heatmap

    • 10.6. Top Player Positioning,2022

  • CHAPTER 11: COMPANY PROFILES

    • 11.1. B. Braun Melsungen AG

      • 11.1.1. Company Overview

      • 11.1.2. Key Executives

      • 11.1.3. Company Snapshot

      • 11.1.4. Operating Business Segments

      • 11.1.5. Product Portfolio

      • 11.1.6. Business Performance

      • 11.1.7. Key Strategic Moves and Developments

    • 11.2. BioMedtrix

      • 11.2.1. Company Overview

      • 11.2.2. Key Executives

      • 11.2.3. Company Snapshot

      • 11.2.4. Operating Business Segments

      • 11.2.5. Product Portfolio

      • 11.2.6. Business Performance

      • 11.2.7. Key Strategic Moves and Developments

    • 11.3. Corin

      • 11.3.1. Company Overview

      • 11.3.2. Key Executives

      • 11.3.3. Company Snapshot

      • 11.3.4. Operating Business Segments

      • 11.3.5. Product Portfolio

      • 11.3.6. Business Performance

      • 11.3.7. Key Strategic Moves and Developments

    • 11.4. Evolutis India Pvt. Ltd.

      • 11.4.1. Company Overview

      • 11.4.2. Key Executives

      • 11.4.3. Company Snapshot

      • 11.4.4. Operating Business Segments

      • 11.4.5. Product Portfolio

      • 11.4.6. Business Performance

      • 11.4.7. Key Strategic Moves and Developments

    • 11.5. Johnson And Johnson Services Inc.

      • 11.5.1. Company Overview

      • 11.5.2. Key Executives

      • 11.5.3. Company Snapshot

      • 11.5.4. Operating Business Segments

      • 11.5.5. Product Portfolio

      • 11.5.6. Business Performance

      • 11.5.7. Key Strategic Moves and Developments

    • 11.6. Limacorporate S.p.a.

      • 11.6.1. Company Overview

      • 11.6.2. Key Executives

      • 11.6.3. Company Snapshot

      • 11.6.4. Operating Business Segments

      • 11.6.5. Product Portfolio

      • 11.6.6. Business Performance

      • 11.6.7. Key Strategic Moves and Developments

    • 11.7. Mathys Ltd

      • 11.7.1. Company Overview

      • 11.7.2. Key Executives

      • 11.7.3. Company Snapshot

      • 11.7.4. Operating Business Segments

      • 11.7.5. Product Portfolio

      • 11.7.6. Business Performance

      • 11.7.7. Key Strategic Moves and Developments

    • 11.8. Bettlach

      • 11.8.1. Company Overview

      • 11.8.2. Key Executives

      • 11.8.3. Company Snapshot

      • 11.8.4. Operating Business Segments

      • 11.8.5. Product Portfolio

      • 11.8.6. Business Performance

      • 11.8.7. Key Strategic Moves and Developments

    • 11.9. Beijing Chunlizhengda Medical Instruments Co.

      • 11.9.1. Company Overview

      • 11.9.2. Key Executives

      • 11.9.3. Company Snapshot

      • 11.9.4. Operating Business Segments

      • 11.9.5. Product Portfolio

      • 11.9.6. Business Performance

      • 11.9.7. Key Strategic Moves and Developments

    • 11.10. Ltd.

      • 11.10.1. Company Overview

      • 11.10.2. Key Executives

      • 11.10.3. Company Snapshot

      • 11.10.4. Operating Business Segments

      • 11.10.5. Product Portfolio

      • 11.10.6. Business Performance

      • 11.10.7. Key Strategic Moves and Developments

    • 11.11. Biotech GmbH

      • 11.11.1. Company Overview

      • 11.11.2. Key Executives

      • 11.11.3. Company Snapshot

      • 11.11.4. Operating Business Segments

      • 11.11.5. Product Portfolio

      • 11.11.6. Business Performance

      • 11.11.7. Key Strategic Moves and Developments

    • 11.12. CeramTec Group

      • 11.12.1. Company Overview

      • 11.12.2. Key Executives

      • 11.12.3. Company Snapshot

      • 11.12.4. Operating Business Segments

      • 11.12.5. Product Portfolio

      • 11.12.6. Business Performance

      • 11.12.7. Key Strategic Moves and Developments

    • 11.13. Elite Surgical

      • 11.13.1. Company Overview

      • 11.13.2. Key Executives

      • 11.13.3. Company Snapshot

      • 11.13.4. Operating Business Segments

      • 11.13.5. Product Portfolio

      • 11.13.6. Business Performance

      • 11.13.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR DEMINERALIZED BONE MATRIX, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR ALLOGRAFT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR BONE MORPHOGENETIC PROTEIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR VISCOSUPPLEMENTATION PRODUCTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR SYNTHETIC BONE SUBSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR KNEE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR HIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR SHOULDER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR ANKLE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR JOINT REPLACEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR BONE GRAFT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR OSTEOTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR ARTHROSCOPY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR RESURFACING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR ARTHRODESIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 23. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR METALLIC, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR POLYMERIC, BY REGION, 2022-2032 ($MILLION)
  • TABLE 25. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR CERAMIC, BY REGION, 2022-2032 ($MILLION)
  • TABLE 26. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR NATURAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 27. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 29. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR AMBULATORY CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 30. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR RESEARCH ACADEMIC INSTITUTE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 31. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 32. NORTH AMERICA ORTHOPEDIC JOINT RECONSTRUCTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 33. NORTH AMERICA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. NORTH AMERICA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. NORTH AMERICA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 36. NORTH AMERICA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 37. NORTH AMERICA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. U.S. ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. U.S. ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 40. U.S. ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 41. U.S. ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 42. U.S. ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. CANADA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. CANADA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. CANADA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 46. CANADA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 47. CANADA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. MEXICO ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 49. MEXICO ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. MEXICO ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 51. MEXICO ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 52. MEXICO ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 54. EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 55. EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 57. EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 58. EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. FRANCE ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. FRANCE ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 61. FRANCE ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 62. FRANCE ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 63. FRANCE ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. GERMANY ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 65. GERMANY ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. GERMANY ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 67. GERMANY ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 68. GERMANY ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. ITALY ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 70. ITALY ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 71. ITALY ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 72. ITALY ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 73. ITALY ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. SPAIN ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 75. SPAIN ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 76. SPAIN ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 77. SPAIN ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 78. SPAIN ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. UK ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 80. UK ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 81. UK ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 82. UK ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 83. UK ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. RUSSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 85. RUSSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 86. RUSSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 87. RUSSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 88. RUSSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. REST OF EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 90. REST OF EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 91. REST OF EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 92. REST OF EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 93. REST OF EUROPE ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. ASIA-PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 95. ASIA-PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 96. ASIA-PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 97. ASIA-PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 98. ASIA-PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 99. ASIA-PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. CHINA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 101. CHINA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 102. CHINA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 103. CHINA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 104. CHINA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. JAPAN ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 106. JAPAN ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 107. JAPAN ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 108. JAPAN ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 109. JAPAN ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 110. INDIA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 111. INDIA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 112. INDIA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 113. INDIA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 114. INDIA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 115. SOUTH KOREA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 116. SOUTH KOREA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 117. SOUTH KOREA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 118. SOUTH KOREA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 119. SOUTH KOREA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 120. AUSTRALIA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 121. AUSTRALIA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 122. AUSTRALIA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 123. AUSTRALIA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 124. AUSTRALIA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. THAILAND ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 126. THAILAND ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 127. THAILAND ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 128. THAILAND ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 129. THAILAND ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 130. MALAYSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 131. MALAYSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 132. MALAYSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 133. MALAYSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 134. MALAYSIA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 135. INDONESIA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 136. INDONESIA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 137. INDONESIA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 138. INDONESIA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 139. INDONESIA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 140. REST OF ASIA PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 141. REST OF ASIA PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 142. REST OF ASIA PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 143. REST OF ASIA PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 144. REST OF ASIA PACIFIC ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 145. LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 146. LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 147. LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 148. LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 149. LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 150. LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 151. BRAZIL ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 152. BRAZIL ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 153. BRAZIL ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 154. BRAZIL ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 155. BRAZIL ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 156. SOUTH AFRICA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 157. SOUTH AFRICA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 158. SOUTH AFRICA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 159. SOUTH AFRICA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 160. SOUTH AFRICA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 161. SAUDI ARABIA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 162. SAUDI ARABIA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 163. SAUDI ARABIA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 164. SAUDI ARABIA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 165. SAUDI ARABIA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 166. UAE ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 167. UAE ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 168. UAE ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 169. UAE ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 170. UAE ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 171. ARGENTINA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 172. ARGENTINA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 173. ARGENTINA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 174. ARGENTINA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 175. ARGENTINA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 176. REST OF LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 177. REST OF LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY JOINT TYPE, 2022-2032 ($MILLION)
  • TABLE 178. REST OF LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 179. REST OF LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY BIOMATERIAL, 2022-2032 ($MILLION)
  • TABLE 180. REST OF LAMEA ORTHOPEDIC JOINT RECONSTRUCTION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 181. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 182. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 183. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 184. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 185. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 186. BIOMEDTRIX: KEY EXECUTIVES
  • TABLE 187. BIOMEDTRIX: COMPANY SNAPSHOT
  • TABLE 188. BIOMEDTRIX: OPERATING SEGMENTS
  • TABLE 189. BIOMEDTRIX: PRODUCT PORTFOLIO
  • TABLE 190. BIOMEDTRIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 191. CORIN: KEY EXECUTIVES
  • TABLE 192. CORIN: COMPANY SNAPSHOT
  • TABLE 193. CORIN: OPERATING SEGMENTS
  • TABLE 194. CORIN: PRODUCT PORTFOLIO
  • TABLE 195. CORIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 196. EVOLUTIS INDIA PVT. LTD.: KEY EXECUTIVES
  • TABLE 197. EVOLUTIS INDIA PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 198. EVOLUTIS INDIA PVT. LTD.: OPERATING SEGMENTS
  • TABLE 199. EVOLUTIS INDIA PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 200. EVOLUTIS INDIA PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 201. JOHNSON AND JOHNSON SERVICES INC.: KEY EXECUTIVES
  • TABLE 202. JOHNSON AND JOHNSON SERVICES INC.: COMPANY SNAPSHOT
  • TABLE 203. JOHNSON AND JOHNSON SERVICES INC.: OPERATING SEGMENTS
  • TABLE 204. JOHNSON AND JOHNSON SERVICES INC.: PRODUCT PORTFOLIO
  • TABLE 205. JOHNSON AND JOHNSON SERVICES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 206. LIMACORPORATE S.P.A.: KEY EXECUTIVES
  • TABLE 207. LIMACORPORATE S.P.A.: COMPANY SNAPSHOT
  • TABLE 208. LIMACORPORATE S.P.A.: OPERATING SEGMENTS
  • TABLE 209. LIMACORPORATE S.P.A.: PRODUCT PORTFOLIO
  • TABLE 210. LIMACORPORATE S.P.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 211. MATHYS LTD: KEY EXECUTIVES
  • TABLE 212. MATHYS LTD: COMPANY SNAPSHOT
  • TABLE 213. MATHYS LTD: OPERATING SEGMENTS
  • TABLE 214. MATHYS LTD: PRODUCT PORTFOLIO
  • TABLE 215. MATHYS LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 216. BETTLACH: KEY EXECUTIVES
  • TABLE 217. BETTLACH: COMPANY SNAPSHOT
  • TABLE 218. BETTLACH: OPERATING SEGMENTS
  • TABLE 219. BETTLACH: PRODUCT PORTFOLIO
  • TABLE 220. BETTLACH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 221. BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO.: KEY EXECUTIVES
  • TABLE 222. BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO.: COMPANY SNAPSHOT
  • TABLE 223. BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO.: OPERATING SEGMENTS
  • TABLE 224. BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO.: PRODUCT PORTFOLIO
  • TABLE 225. BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 226. LTD.: KEY EXECUTIVES
  • TABLE 227. LTD.: COMPANY SNAPSHOT
  • TABLE 228. LTD.: OPERATING SEGMENTS
  • TABLE 229. LTD.: PRODUCT PORTFOLIO
  • TABLE 230. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 231. BIOTECH GMBH: KEY EXECUTIVES
  • TABLE 232. BIOTECH GMBH: COMPANY SNAPSHOT
  • TABLE 233. BIOTECH GMBH: OPERATING SEGMENTS
  • TABLE 234. BIOTECH GMBH: PRODUCT PORTFOLIO
  • TABLE 235. BIOTECH GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 236. CERAMTEC GROUP: KEY EXECUTIVES
  • TABLE 237. CERAMTEC GROUP: COMPANY SNAPSHOT
  • TABLE 238. CERAMTEC GROUP: OPERATING SEGMENTS
  • TABLE 239. CERAMTEC GROUP: PRODUCT PORTFOLIO
  • TABLE 240. CERAMTEC GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 241. ELITE SURGICAL: KEY EXECUTIVES
  • TABLE 242. ELITE SURGICAL: COMPANY SNAPSHOT
  • TABLE 243. ELITE SURGICAL: OPERATING SEGMENTS
  • TABLE 244. ELITE SURGICAL: PRODUCT PORTFOLIO
  • TABLE 245. ELITE SURGICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ORTHOPEDIC JOINT RECONSTRUCTION MARKET
  • FIGURE 3. SEGMENTATION ORTHOPEDIC JOINT RECONSTRUCTION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ORTHOPEDIC JOINT RECONSTRUCTION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALORTHOPEDIC JOINT RECONSTRUCTION MARKET
  • FIGURE 11. ORTHOPEDIC JOINT RECONSTRUCTION MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR DEMINERALIZED BONE MATRIX, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR ALLOGRAFT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR BONE MORPHOGENETIC PROTEIN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR VISCOSUPPLEMENTATION PRODUCTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR SYNTHETIC BONE SUBSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. ORTHOPEDIC JOINT RECONSTRUCTION MARKET SEGMENTATION, BY BY JOINT TYPE
  • FIGURE 19. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR KNEE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR HIP, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR SHOULDER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR ANKLE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. ORTHOPEDIC JOINT RECONSTRUCTION MARKET SEGMENTATION, BY BY TECHNIQUE
  • FIGURE 25. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR JOINT REPLACEMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR BONE GRAFT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR OSTEOTOMY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR ARTHROSCOPY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR RESURFACING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR ARTHRODESIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. ORTHOPEDIC JOINT RECONSTRUCTION MARKET SEGMENTATION, BY BY BIOMATERIAL
  • FIGURE 33. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR METALLIC, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 34. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR POLYMERIC, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 35. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR CERAMIC, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 36. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR NATURAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 37. ORTHOPEDIC JOINT RECONSTRUCTION MARKET SEGMENTATION, BY BY END USER
  • FIGURE 38. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 39. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR AMBULATORY CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 40. ORTHOPEDIC JOINT RECONSTRUCTION MARKET FOR RESEARCH ACADEMIC INSTITUTE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45. COMPETITIVE DASHBOARD
  • FIGURE 46. COMPETITIVE HEATMAP: ORTHOPEDIC JOINT RECONSTRUCTION MARKET
  • FIGURE 47. Top player positioning, 2022
  • FIGURE 48. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. BIOMEDTRIX: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. BIOMEDTRIX: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. BIOMEDTRIX: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. CORIN: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. CORIN: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. CORIN: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. EVOLUTIS INDIA PVT. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. EVOLUTIS INDIA PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. EVOLUTIS INDIA PVT. LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. JOHNSON AND JOHNSON SERVICES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. JOHNSON AND JOHNSON SERVICES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. JOHNSON AND JOHNSON SERVICES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. LIMACORPORATE S.P.A.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. LIMACORPORATE S.P.A.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. LIMACORPORATE S.P.A.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. MATHYS LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. MATHYS LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. MATHYS LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 69. BETTLACH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 70. BETTLACH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 71. BETTLACH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 72. BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 73. BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 74. BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 75. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 76. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 77. LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 78. BIOTECH GMBH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 79. BIOTECH GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 80. BIOTECH GMBH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 81. CERAMTEC GROUP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 82. CERAMTEC GROUP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 83. CERAMTEC GROUP: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 84. ELITE SURGICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 85. ELITE SURGICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 86. ELITE SURGICAL: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Orthopedic Joint Reconstruction Market

Start reading.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers